NET PROFIT (x1000 EUR)
EMPLOYEES
Derma Pharm A/S
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
3,204
|
1,543
|
675 |
| Total assets |
20,045
|
17,415
|
16,478 |
| Current assets |
14,004
|
12,236
|
11,289 |
| Current liabilities |
9,913
|
8,936
|
8,445 |
| Equity capital |
7,995
|
6,253
|
5,316 |
| - share capital |
134
|
134
|
134 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
39.9%
|
35.9%
|
32.3% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
141.3%
|
136.9%
|
133.7% |
| Return on equity (ROE) |
40.1%
|
24.7%
|
12.7% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.